ArticleNature medicine2022

PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial.

Vivek Narayan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.